PROCEPT BioRoboticsĀ® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance
Go back to PROCEPT BioRoboticsĀ® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance| (NASDAQ: PRCT) | Delayed: 21.19 -1.57 (6.9%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.76 | 52 Week High | $ | |||
| Open | $22.49 | 52 Week Low | $ | |||
| Day High | $22.56 | P/E | N/A | |||
| Day Low | $21.18 | EPS | $ | |||
| Volume | 264,878 | |||||

